Cardiac Safety of (Neo)Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience

BACKGROUND: Trastuzumab improves the survival of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). The incidence and long-term impact of trastuzumab-related cardiotoxicity in the community setting is of great clinical importance. MATERIAL AND METHODS: Patient...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: da Fonseca, Leonardo Gomes, de Melo Gagliato, Debora, Takahashi, Tiago K., Mak, Milena Perez, Barroso-Sousa, Romualdo, Testa, Laura, Helena, Vanessa Petry, de Paula Costa, Romulo, Hoff, Paulo M., Mano, Max S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger GmbH 2014
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209270/
https://ncbi.nlm.nih.gov/pubmed/25404884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000365950
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi